A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)

NCT00926185 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
230
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire